Friday, October 30, 2009

Three At Last, Three At Last!

Thank God Almighty, we're three at last!

The two of us -- Beck and Herrmann, the blogging fools -- started the Drug and Device Law Blog three years ago today, on October 30, 2006.

Here's how we celebrated on October 30, 2007.

We turned philosophical on October 30, 2008.

And today, at three, we're just old.

Here's how old:

1042 posts.

Nearly 500 readers subscribing by our Google group (that is, by typing their e-mail addresses in the blank over in the right-hand column of the blog).

Just north of 250 subscribing by RSS feeds. (That's "really simple syndication," although it doesn't seem so simple to us. If you don't understand RSS feeds, we're surely not the ones to explain.)

Roughly 350 subscribing by Twitter. (They receive only the headlines of our posts and must then choose to read the bodies.)

And 20,000 to 30,000 more pageviews each month from non-subscribers who just come to take a look.

We can no longer tell how many folks have visited our blog, because people who subscribe by the Google group (and thus receive every post by e-mail) don't show up in the tracking system. But we've surely had more than 600,000 pageviews since we started this gig, and it's possible we're pretty far north of that figure.

That's many more readers than we anticipated would come when we started typing three years ago, and we're gratified by the response.

We particularly appreciate the many folks who contact us off-line to pass on breaking news, share strategies, and otherwise help us to keep our ears close to the ground. (With our ears on the ground and our fingers on the keyboard, we're a sight to be seen.)

Thanks for visiting -- and have a piece of cake, on us!

1 comment:

Tom Lamb said...

Jim and Mark:

Thanks for the time and effort which you have consistently put into this invaluable resource.

As I hope you know, the Drug and Device Law blog is greatly appreciated by many more people than those subscriber numbers indicate.

The depth of your posts and the unique insights which you offer are unsurpassed in this part of the blogosphere.

Keep up the good work guys.


Tom Lamb
DrugInjuryWatch.com